Wenxian Wu

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsMedical devicesBiologically active moleculesCell development, proliferation and deathCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 15, 2025
The ER protein CANX (calnexin)-mediated autophagy protects against alzheimer disease.

Hongtao Shen, Yuying Xie, Yan Wang

|Mar 06, 2024
Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity.

Shuaiya Ma, Qi Wu, Wenxian Wu

|Jun 01, 2021
High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol.

Jana Deitersen, Lena Berning, Fabian Stuhldreier

|Mar 29, 2021
TNF-induced necroptosis initiates early autophagy events via RIPK3-dependent AMPK activation, but inhibits late autophagy.

Wenxian Wu, Xiaojing Wang, Yadong Sun

|Mar 06, 2021
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment.

Lena Berning, David Schlütermann, Annabelle Friedrich

|Sep 18, 2020
The phospho-barcode of RIPK1: complementarity or redundancy?

Wenxian Wu, Björn Stork

Pageof 2

Frequent Collaborators

6 joint publications

Björn Stork

1 joint publications

Margaretha A Skowron

1 joint publications

Michèle J Hoffmann

1 joint publications

Günter Niegisch